Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)
Company Info
| ISIN | CNE100001M79 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | HK$84.95B |
|---|---|
| EPS | HK$1.61 |
| PE Ratio | 11.73 |
| PEG Ratio | 1.00 |
| Revenue (TTM) | HK$44.44B |
| Gross Profit (TTM) | HK$20.70B |
| EBITDA (TTM) | HK$5.90B |
| Year Range | HK$17.36 - HK$34.00 |
| Target Price | HK$32.42 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of HK$10,000 in Shanghai Fosun Pharmaceutical Group Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Shanghai Fosun Pharmaceutical Group Co Ltd had a return of -16.00% year-to-date (YTD) and -33.11% in the last 12 months. Over the past 10 years, Shanghai Fosun Pharmaceutical Group Co Ltd had an annualized return of 5.61%, while the S&P 500 had an annualized return of 10.63%, indicating that Shanghai Fosun Pharmaceutical Group Co Ltd did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -6.87% | 3.19% |
| Year-To-Date | -16.00% | 9.50% |
| 6 months | -13.04% | 4.00% |
| 1 year | -33.11% | -2.77% |
| 5 years (annualized) | -14.32% | 8.73% |
| 10 years (annualized) | 5.61% | 10.63% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 0.80% | -8.93% | -2.83% | 0.22% | -4.70% | |||||||
| 2022 | 30.17% | -3.10% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
2196.HK Shanghai Fosun Pharmaceutical Group Co Ltd | -0.76 | ||||
^GSPC S&P 500 | 0.21 |
Dividend History
Shanghai Fosun Pharmaceutical Group Co Ltd granted a 3.14% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.66 per share.
| Period | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.66 | HK$0.66 | HK$0.52 | HK$0.43 | HK$0.36 | HK$0.46 | HK$0.40 | HK$0.38 | HK$0.36 | HK$0.34 | HK$0.26 |
Dividend yield | 3.14% | 2.64% | 1.55% | 1.21% | 1.61% | 2.14% | 0.86% | 1.75% | 1.76% | 1.38% | 1.28% |
Monthly Dividends
The table displays the monthly dividend distributions for Shanghai Fosun Pharmaceutical Group Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.66 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.52 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.43 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.36 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.46 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.40 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.38 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.36 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2014 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.34 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2013 | HK$0.26 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Shanghai Fosun Pharmaceutical Group Co Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Shanghai Fosun Pharmaceutical Group Co Ltd is 76.58%, recorded on Oct 11, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -76.58% | Aug 5, 2021 | 292 | Oct 11, 2022 | — | — | — |
| -62.8% | Mar 21, 2018 | 489 | Mar 16, 2020 | 278 | May 3, 2021 | 767 |
| -50.19% | Jun 1, 2015 | 162 | Jan 21, 2016 | 338 | Jun 8, 2017 | 500 |
| -21.94% | Jan 15, 2018 | 20 | Feb 9, 2018 | 25 | Mar 20, 2018 | 45 |
| -19.74% | Mar 12, 2014 | 26 | Apr 16, 2014 | 247 | Apr 21, 2015 | 273 |
Volatility Chart
The current Shanghai Fosun Pharmaceutical Group Co Ltd volatility is 8.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.